HimachandanaAtluriMD

Internal Medicine • Chicago, IL

Hematology/Oncology

Physician

Join to view full profile

Dr. Atluri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Atluri's full profile

Already have an account?

Office
676 N Saint Clair St
Ste 850
Chicago, IL 60611
Phone+1 312-695-6180

Fax+1 312-695-6189

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2021 - 2024
Washington University/B-JH/SLCH ConsortiumChief Residency, Internal Medicine, 2020 - 2021
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2017 - 2020
University of Missouri Kansas City School of MedicineClass of 2017

Certifications & Licensure

IL State Medical License 2020 - 2026
MO State Medical License 2017 - 2025
TX State Medical License 2021 - 2025
American Board of Internal Medicine Internal Medicine

Clinical Trials

Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation Start of enrollment: 2020 Apr 07
Completed
Phase 1

Publications & Presentations

PubMed

3 citations
Risk factors for mortality and multidrug resistance in pulmonary tuberculosis in Guatemala: A retrospective analysis of mandatory reporting.
Kevin Montes, Himachandana Atluri, Hibeb Silvestre Tuch, Lucrecia Ramirez, Juan Paiz
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2021-11-15
14 citations
A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.
Anna R Damato, Ruth G N Katumba, Jingqin Luo, Himachandana Atluri, Grayson R Talcott
Neuro-Oncology Practice. 2022-05-01
4 citations
Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Himachandana Atluri, Yoheved S Gerstein, Courtney D DiNardo
Current Hematologic Malignancy Reports. 2022-12-01

Abstracts/Posters

Effect of temozolomide chronotherapy in patients with high-grade glioma
Atluri, H., Campian, JL., Talcott, G., Meyer, M., Slat, E., Rubin, J., Tao, Y., Hung, J., Chheda, MG., Johanns, T., Govindan, A., Journal of Clinical Oncology, 5/25/2020

Press Mentions

Can Leukemia Be Treated with a Pill?August 8th, 2024

Professional Memberships

Alpha Omega Alpha Honor Medical Society - AOA
Member
American College of Physicians - ACP
Member
American Medical Association - AMA
Member